These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8056282

  • 21. Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
    Bonomo RA, Rudin SA, Shlaes DM.
    FEMS Microbiol Lett; 1997 Mar 01; 148(1):59-62. PubMed ID: 9066111
    [Abstract] [Full Text] [Related]

  • 22. Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.
    Stapleton PD, Shannon KP, French GL.
    Antimicrob Agents Chemother; 1999 Aug 01; 43(8):1881-7. PubMed ID: 10428907
    [Abstract] [Full Text] [Related]

  • 23. Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics.
    Chaïbi EB, Sirot D, Paul G, Labia R.
    J Antimicrob Chemother; 1999 Apr 01; 43(4):447-58. PubMed ID: 10350372
    [Abstract] [Full Text] [Related]

  • 24. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.
    Thomson CJ, Amyes SG.
    J Antimicrob Chemother; 1993 May 01; 31(5):655-64. PubMed ID: 8392995
    [Abstract] [Full Text] [Related]

  • 25. [Characterization of the resistance to combinations of beta lactams and inhibitors of beta-lactamases in Escherichia coli. Effect of the type and amount of beta-lactamase production].
    del Mar Pérez-Moreno M, Pous-Miralles G, Romera-Sastre G, Panisello-Bertomeu JM, Jardí-Baiges AM, Zarazoga-López J.
    Enferm Infecc Microbiol Clin; 1997 Nov 01; 15(9):477-81. PubMed ID: 9527373
    [Abstract] [Full Text] [Related]

  • 26. TEM-109 (CMT-5), a natural complex mutant of TEM-1 beta-lactamase combining the amino acid substitutions of TEM-6 and TEM-33 (IRT-5).
    Robin F, Delmas J, Chanal C, Sirot D, Sirot J, Bonnet R.
    Antimicrob Agents Chemother; 2005 Nov 01; 49(11):4443-7. PubMed ID: 16251281
    [Abstract] [Full Text] [Related]

  • 27. Catalytic and structural properties of IRT-21 beta-lactamase (TEM-77) from a co-amoxiclav-resistant Proteus mirabilis isolate.
    Mammeri H, Gilly L, Laurans G, Vedel G, Eb F, Paul G.
    FEMS Microbiol Lett; 2001 Dec 18; 205(2):185-9. PubMed ID: 11750800
    [Abstract] [Full Text] [Related]

  • 28. Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended-spectrum beta-lactamase, TEM-60.
    Franceschini N, Perilli M, Segatore B, Setacci D, Amicosante G, Mazzariol A, Cornaglia G.
    Antimicrob Agents Chemother; 1998 Jun 18; 42(6):1459-62. PubMed ID: 9624494
    [Abstract] [Full Text] [Related]

  • 29. Nucleotide sequences of the genes coding for the TEM-like beta-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2).
    Belaaouaj A, Lapoumeroulie C, Caniça MM, Vedel G, Névot P, Krishnamoorthy R, Paul G.
    FEMS Microbiol Lett; 1994 Jul 01; 120(1-2):75-80. PubMed ID: 8056297
    [Abstract] [Full Text] [Related]

  • 30. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ, Cartelle M, Mallo S, Beceiro A, Pérez A, Villanueva R, Romero A, Bonnet R, Bou G.
    J Antimicrob Chemother; 2008 Apr 01; 61(4):792-7. PubMed ID: 18281307
    [Abstract] [Full Text] [Related]

  • 31. Experimental application of the median-effect principle for in vitro quantification of the combined inhibitory activities of clavulanic acid and imipenem against IRT-4 beta-lactamase.
    Sotto A, Foulongne V, Sirot D, Labia R, Jourdan J.
    Int J Antimicrob Agents; 2002 Jan 01; 19(1):75-8. PubMed ID: 11814772
    [Abstract] [Full Text] [Related]

  • 32. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH, Hu ZQ, Chen G, Ito R, Shimamura T.
    Chemotherapy; 2008 Jan 01; 54(1):31-7. PubMed ID: 18063864
    [Abstract] [Full Text] [Related]

  • 33. Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
    Papp-Wallace KM, Taracila M, Hornick JM, Hujer AM, Hujer KM, Distler AM, Endimiani A, Bonomo RA.
    Antimicrob Agents Chemother; 2010 Jul 01; 54(7):2867-77. PubMed ID: 20421396
    [Abstract] [Full Text] [Related]

  • 34. A piperacillin-tazobactam resistant Escherichia coli strain isolated from a faecal sample of a healthy volunteer.
    London N, Thomson CJ, Amyes SG, Stobberingh E.
    FEMS Immunol Med Microbiol; 1995 Apr 01; 11(2):107-11. PubMed ID: 7640670
    [Abstract] [Full Text] [Related]

  • 35. Novel mechanisms of resistance to β-lactam antibiotics in Haemophilus parainfluenzae: β-lactamase-negative ampicillin resistance and inhibitor-resistant TEM β-lactamases.
    García-Cobos S, Arroyo M, Campos J, Pérez-Vázquez M, Aracil B, Cercenado E, Orden B, Lara N, Oteo J.
    J Antimicrob Chemother; 2013 May 01; 68(5):1054-9. PubMed ID: 23335113
    [Abstract] [Full Text] [Related]

  • 36. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM, Ueno Y, Cunha BA.
    Chemotherapy; 1996 May 01; 42(5):334-42. PubMed ID: 8874972
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. First characterization of inhibitor-resistant TEM (IRT) beta-lactamases in Klebsiella pneumoniae strains.
    Lemozy J, Sirot D, Chanal C, Huc C, Labia R, Dabernat H, Sirot J.
    Antimicrob Agents Chemother; 1995 Nov 01; 39(11):2580-2. PubMed ID: 8585751
    [Abstract] [Full Text] [Related]

  • 39. Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli.
    Rodríguez-Villodres Á, Gil-Marqués ML, Álvarez-Marín R, Bonnin RA, Pachón-Ibáñez ME, Aguilar-Guisado M, Naas T, Aznar J, Pachón J, Lepe JA, Smani Y.
    J Antimicrob Chemother; 2020 Jan 01; 75(1):77-85. PubMed ID: 31613964
    [Abstract] [Full Text] [Related]

  • 40. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
    Papp-Wallace KM, Winkler ML, Taracila MA, Bonomo RA.
    Antimicrob Agents Chemother; 2015 Jul 01; 59(7):3710-7. PubMed ID: 25666153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.